1. Home
  2. CSV vs ANNX Comparison

CSV vs ANNX Comparison

Compare CSV & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carriage Services Inc.

CSV

Carriage Services Inc.

HOLD

Current Price

$48.58

Market Cap

659.5M

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$6.39

Market Cap

730.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSV
ANNX
Founded
1991
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
659.5M
730.4M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CSV
ANNX
Price
$48.58
$6.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$59.00
$16.50
AVG Volume (30 Days)
89.8K
2.5M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
0.92%
N/A
EPS Growth
54.76
N/A
EPS
3.25
N/A
Revenue
$417,440,000.00
N/A
Revenue This Year
$7.35
N/A
Revenue Next Year
$3.87
$16,320.74
P/E Ratio
$14.96
N/A
Revenue Growth
3.28
N/A
52 Week Low
$38.10
$1.60
52 Week High
$49.41
$7.18

Technical Indicators

Market Signals
Indicator
CSV
ANNX
Relative Strength Index (RSI) 66.29 61.56
Support Level $43.62 $4.79
Resistance Level $49.29 $6.50
Average True Range (ATR) 1.07 0.43
MACD 0.18 0.09
Stochastic Oscillator 87.94 85.19

Price Performance

Historical Comparison
CSV
ANNX

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: